Back to discover
Drug

Oxytocin

In clinical development
ClassOxytocin receptor agonistEmerging researchLate-stage developmentRising momentum

Also known as Oxitocina, Pitocin.

19
Research papers
10
Active clinical trials
Oxytocin receptor
Primary target
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Benefits of Oxytocin in OSA Patients Using CPAP

Clinical trial2026-05-04Results expected Q4 2026 · ClinicalTrials.gov

The Modulatory Effects of Oxytocin on Emotional Processing and Its Acting Routes

Clinical trial2026-04-15Primary completion · ClinicalTrials.gov

Enhancing Prolonged Exposure Therapy for PTSD With Oxytocin

Clinical trial2026-03-11Results posted · ClinicalTrials.gov

Mechanisms Underlying Oxytocin's Analgesia in Older Adults

Clinical trial2026-02-23Results posted · ClinicalTrials.gov

The Clinical Carbetocin Myocardium Trial Part 2

Clinical trial2026-02-10Results posted · ClinicalTrials.gov

Social anxiety disorder-associated gut microbiota increases social fear.

Research2023-12-26Proceedings of the National Academy of Sciences of the United States of America

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Oxytocin
Aliases & brands
OxitocinaPitocin
RxNorm CUI
7824
ChEMBL ID
CHEMBL395429
ATC codes
H01BB02
UNII
1JQS135EYN
Primary mechanism
Oxytocin receptor agonist

Pharmacology & targets

1 target

Known molecular targets and mechanisms supported by curated pharmacology databases.

Oxytocin receptor
OXTR · P30559
AGONISTOxytocin receptor agonist

Clinical trials

194 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
194
registered trials across all phases
LATEST COMPLETION 2025
10
Active studies
10
Recruiting
125
Late-stage (III+)
129
Completed
55
Discontinued
PHASE DISTRIBUTIONn = 194
Early Phase 114Phase 117Phase 1 / 24Phase 234Phase 2 / 36Phase 314Phase 431Phase N / A74

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

19 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19962025
Most influential
Recent papers
Major research themes8
Oxytocin4Labor, Induced2Neurons2Social Behavior2Astrocytes1Autism Spectrum Disorder1Catheterization1Chromosome Disorders1
Journals, researchers & institutions
Top journals
  • Obstetrics and gynecology4
  • American journal of obstetrics and gynecology2
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2
  • Annual review of neuroscience1
  • Journal of physiology, Paris1
  • Molecular autism1
Leading researchers
  • Bascoul C2
  • Çabal-Berthoumieu S2
  • Cohen D2
  • Diene G2
  • Faye S2
  • Fichaux-Bourin P2
  • Guedeney A2
  • Molinas C2
Leading institutions
free-text, unnormalised
  • Alimentary Pharmabiotic Centre Microbiome Ireland1
  • Axe Pédiatrique du Centre d'Investigation Clinique 9302/Intitut National de la Santé Et de la Recherche Médicale1
  • Center for Neural Science1
  • Center for Social Neural Networks1
  • Center for Women's Reproductive Health and Maternal-Fetal Medicine Division1
  • Centre de Référence du Syndrome de Prader-Willi1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Frequently co-studied with Oxytocin in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials